Resources

This document summarises the Medicare Benefits Schedule (MBS) Review Taskforce’s recommendations in response to the Obstetrics Clinical Committee report.

This report contains the recommendations the Pathology Clinical Committee made to the MBS Review Taskforce about tissue (anatomical) pathology/cytology items, after public consultation.

We want to work effectively with our stakeholders — to listen, learn and continue to improve our performance. To do this we use 5 principles to help our engagement. We are purposeful, inclusive, timely, transparent and respectful.

Australian Government response to House of Representatives Standing Committee on Health report: Skin cancer in Australia – our national cancer

A summary of the major items discussed at the second MDAF meeting.

This summary report provides a high level overview of the Perfluorinated chemicals in food – consolidated report.

This report from Food Standards Australia New Zealand (FSANZ) includes health based guidance values for site investigations in Australia, a dietary exposure assessment and risk management advice for authorities investigating per- and polyfluoroalkyl substances (PFAS) contamination.

This report reviews reports from the United States Environmental Protection Authority on perfluoroalkylated substances. It focusses on the validity of the pharmacokinetic (PK) modelling and summarises assumptions, limitations and uncertainties.

This report provide advice on appropriate health-based guidance values for perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA), and to consider whether either a separate or group HBGV can be established for perfluorohexane sulfonate (PFHxS).

This report assesses animal toxicology and epidemiology material for effects of perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) on the immune system.

This summary report provides a high level overview of the Perfluorinated chemicals in food – hazard assessment.

This report provides a preliminary dietary exposure report on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and perfluorohexane sulfonate (PFHxS).

This literature review examines the occurrence of, and reported estimates of dietary exposure to perfluroalylated substances (PFAS) in various populations.

This report contains final analytical data sets representing food from contaminated areas for use in dietary exposure calculations.

This summary report provides a high level overview of the Perfluorinated chemicals in food – dietary exposure assessment.

This document outlines recommendations for other controls for perfluorinated chemicals in Australia.

This document outlines the criteria used to determine the maximum levels of contaminants in food.

The health based guidance values are expressed as a tolerable daily intake (TDI) and can be used for assessing potential exposure to per- and poly-fluoroalkyl substances (PFAS) through food, drinking water and recreational water during site investigations.

This document contains frequently asked questions about the Perfluorinated chemicals in food report.

These spreadsheets provide 2016 quarterly childhood immunisation coverage data by Primary Health Network (PHN), for all children and Aboriginal and Torres Strait Islander children.

This reports updates a literature review that looked at international and Australian clinical, academic and policy journals, as well as media articles or sources in relation to biosimilar medicines, to help inform policy development and communication activities. It covers September to December 2016.

The Administrative Record Keeping Guidelines provides useful information and tools that support good administrative record keeping within your practice.

BreastScreen Australia services and State Coordination Units (SCUs) use this form to identify which NAS measures they are responsible for as part of the accreditation process.

These guidelines for Public Health Units provide nationally consistent guidance on how to respond to Zika virus. They are part of a Series of National Guidelines (SoNGs) published by the Communicable Diseases Network Australia (CDNA).

This interim report provided the MBS Review Taskforce with a progress update on the work of the General Practice and Primary Care Clinical Committee, as at April 2017.